Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, July 01, 2020 (GLOBE NEWSWIRE) -- Apple Tree Partners (ATP), a leading life sciences venture firm, announced today the creation of Nine Square Therapeutics to discover novel therapies for...
-
ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that pooled efficacy analysis from the four Phase 3 clinical studies of NEXLETOL, an oral, once-daily...
-
SANTA MONICA, Calif., July 01, 2020 (GLOBE NEWSWIRE) -- ALG, Inc., a subsidiary of TrueCar, Inc. and the industry benchmark for determining the future resale value of a vehicle, projects average...
-
SAN DIEGO, June 22, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer,...
-
COMUNICATO STAMPA 19 GIUGNO 2020 Italeaf: la subsidiary algoWatt mette in esercizio l’impianto di bonifica acque di falda e di trattamento rifiuti liquidi industriali Purify ·Il nuovo asset...
-
PRESS RELEASE 19 JUNE 2020 Italeaf: the subsidiary algoWatt put into operation the Purify groundwater remediation and industrial liquid waste treatment plant The new environmental asset put into...
-
New York, June 18, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Non-woven Tapes Industry" - https://www.reportlinker.com/p05899979/?utm_source=GNW An...
-
ANN ARBOR, Mich., June 14, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that pooled analysis from four Phase 3 clinical studies of NEXLETOL were presented at the American...
-
NEW YORK, June 12, 2020 (GLOBE NEWSWIRE) -- Apple Tree Partners (ATP), a leading life sciences fund, will exit its ownership stake in Corvidia Therapeutics, a precision cardiovascular therapeutics...
-
– 5 of 8 (63%) Efficacy Evaluable Patients Achieved a Hemoglobin Increase of ≥1.0 g/dL From Baseline – – Safety Profile Consistent with Previously Published Phase 2 Data for Mitapivat in Patients...